Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropean Metals Holdings Regulatory News (EMH)

Share Price Information for European Metals Holdings (EMH)

Share Price is delayed by 15 minutes
Get Live Data
16.25    -0.75 (-4.41%)
Bid:
16.00
Ask:
16.50
Spread: 0.50 (3.125%)
Market Cap: £38.60m
EMH Live PriceLast checked at - London Stock Exchange

Intraday European Metals Holdings Share Chart

Company Update

11 Nov 2025 09:21

RNS Number : 0479H
European Metals Holdings Limited
11 November 2025
 

Company Update

European Metals Holdings Limited (ASX & AIM: EMH, OTCQX and OTCQB: EMHXY and EMHLF) ("European Metals" or the "Company") provides an update on project funding and the Cinovec Lithium Project's Definitive Feasibility Study ("DFS").

The Company wishes to confirm that all monies due to the Project Company Geomet under the recent cash call have been paid and no amounts are outstanding. The Company informed the market of the cash call in its release of 18 August 2025 and elaborated on the strategy to meet this obligation, confirming in the Company's release of 12 September 2025 the successful completion of the majority of the call.

The Company also takes the opportunity to provide an update on the DFS, with all substantive works now completed and progress with some final works and full documentation continuing, with expected delivery of the results of the study in the first half of December 2025.

Keith Coughlan, Executive Chairman of the Company commented, "Whilst it is disappointing that the DFS is still incomplete, the technical works are now substantially complete. This is a very large and complex project and DRA have done a great job to get us to this stage of near completion."

This announcement has been approved for release by the Board.

CONTACT

For further information on this update or the Company generally, please visit our website at www.europeanmet.com or see full contact details at the end of this release.

ENQUIRIES:

European Metals Holdings Limited

Keith Coughlan, Executive Chairman

 

 

Kiran Morzaria, Non-Executive Director

 

Carly Terzanidis, Company Secretary

 

Tel: +61 (0) 419 996 333

Email: keith@europeanmet.com

 

Tel: +44 (0) 20 7440 0647

 

Tel: +61 (0) 405 469 268

Email: cosec@europeanmet.com

 

Zeus Capital Limited (Nomad & Broker)

James Joyce / Darshan Patel / Gabriella Zwarts

(Corporate Finance)

Harry Ansell (Broking)

 

 

Tel: +44 (0) 203 829 5000

 

BlytheRay (Financial PR)

Tim Blythe

Megan Ray

 

Chapter 1 Advisors (Financial PR - Aus)

David Tasker

 

Tel: +44 (0) 20 7138 3222

 

 

 

 Tel: +61 (0) 433 112 936

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKFLBFEFLFFBK
Date   Source Headline
25th Nov 20228:50 amRNSNotice of Annual General Meeting Results
10th Nov 20227:00 amRNSLithium Specialist Marc Rowley to join EMH/Cinovec
9th Nov 20229:17 amRNSNotice of Annual General Meeting
8th Nov 20227:00 amRNSInvestor Presentation
7th Nov 20228:30 amRNSChange of Director's Interest Notice
31st Oct 202210:02 amRNSQuarterly Activities and Cash Flow Report
31st Oct 202210:00 amRNSSimplified Extraction Process
28th Oct 20227:50 amRNSEngagement of Strategic Energy Investment Adviser
30th Sep 20228:27 amRNSAnnual Governance Statement
30th Sep 20228:11 amRNSAnnual Financial Report
29th Sep 20228:03 amRNSAGM Date and director nominations
9th Sep 202210:48 amRNSChange of Director Shareholding
16th Aug 20227:00 amRNSAppointment of Broker
29th Jul 20227:44 amRNSQuarterly Activities and Cashflow Report
16th Jun 20224:40 pmRNSSecond Price Monitoring Extn
16th Jun 20224:36 pmRNSPrice Monitoring Extension
16th Jun 20228:12 amRNSBecoming a substantial shareholder
12th May 20229:07 amRNSCommencement of Trading on OTCQX Best Market
4th May 20227:00 amRNSInvestor Presentation
29th Apr 20227:20 amRNSQuarterly Activities and Cashflow Report
27th Apr 20227:00 amRNSChange of Company Secretary
16th Mar 20228:26 amRNSHalf-year Report
4th Mar 20227:00 amRNSIssue of Equity
2nd Mar 20227:00 amRNSIssue of Equity
14th Feb 20227:00 amRNSIssue of Equity
2nd Feb 20227:00 amRNSHolding(s) in Company
31st Jan 202212:22 pmRNSQuarterly Activities and Cashflow report
28th Jan 20227:00 amRNSInvestor Presentation
28th Jan 20227:00 amRNSEquity Issue
28th Jan 20227:00 amRNSUpdated Investor Presentation
19th Jan 20229:27 amRNSSuccessful Placing to Raise AUD14.4M
19th Jan 20229:20 amRNSPFS Update Delivers Outstanding Results
24th Nov 202110:57 amRNSNotice of Annual General Meeting Results
23rd Nov 20217:00 amRNSCinovec to Produce Low Carbon Lithium
3rd Nov 20217:06 amRNSAddendum to Notice of Annual General Meeting
29th Oct 202110:16 amRNS3rd Quarter Results
25th Oct 20218:15 amRNSNotice of AGM
13th Oct 20217:00 amRNSResource Upgrade at Cinovec Lithium Project
30th Sep 20219:17 amRNSAnnual Financial Report
30th Sep 20219:06 amRNSAGM Date and director nominations
30th Sep 20219:03 amRNSAnnual Governance Statement
7th Sep 20217:26 amRNSAppointment of Operations Manager
30th Jul 20217:06 amRNSQuarterly Report
27th Jul 20218:18 amRNSLEVEL 1 AMERICAN DEPOSITORY SHARES PROGRAM
16th Jul 20219:53 amRNSIssue of Equity
18th Jun 20217:00 amRNSEMH ADS TO TRADE IN THE U.S.
10th Jun 20217:00 amRNSLITHIUM LIFE CYCLE ASSESSMENT SPECIALIST ENGAGED
28th May 20219:32 amRNSForm TR1 Change in Major Holdings
27th May 20217:00 amRNSAddendum to previous release 19 May 2021
19th May 20218:35 amRNSSTRONG RESULTS FROM LOCKED-CYCLE TESTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.